多肽CRDMO平台
目录肽
大奖888生化目录肽版块全新呈现，致力于打造全球最全面的多肽供应平台！我们专业的学术团队将时刻追踪最新最热的研究动向，帮助您发现实际需求，并以最高质量标准提供您所需要的产品。我们将我们将不定期更新产品列表，为您最大限度地节约科研时间，敬请广大客户朋友关注！
LHRH-019A
Goserelin (free base)\n
Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2
Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2
Size：5
P1(RMB)：426
MW：1269.43
One letter sequence：Pyr-HWSYs(tBu)-LRP-Azagly-NH2
Molecular Formula：C59H84N18O14
Description：Goserelin acetate, a synthetic peptide analog of LHRH, is used in the treatment of prostate cancer, advanced breast cancer and in the management of endometriosesis.
Literature Reference：A.Wells et al., Clin. Cancer Res., 8, 1251 (2002)\nA.Rody et al., Expert Rev. Anticancer Ther., 5, 591 (2005)\nH.Lepor, Rev. Urol., 7 (Suppl. 5), S3 (2005)\nMerck Index, 14th ed., No. 4526, (2006)\nM.Roach 3rd and A.Izaguirre, Expert Opin. Pharmacother., 8, 257 (2007)\nR.M.Herrmann et al., Rad. Oncol., 2, 31 (2007)
Cas：65807-02-5
P1(RMB)：426
MW：1269.43
One letter sequence：Pyr-HWSYs(tBu)-LRP-Azagly-NH2
Molecular Formula：C59H84N18O14
Description：Goserelin acetate, a synthetic peptide analog of LHRH, is used in the treatment of prostate cancer, advanced breast cancer and in the management of endometriosesis.
Literature Reference：A.Wells et al., Clin. Cancer Res., 8, 1251 (2002)\nA.Rody et al., Expert Rev. Anticancer Ther., 5, 591 (2005)\nH.Lepor, Rev. Urol., 7 (Suppl. 5), S3 (2005)\nMerck Index, 14th ed., No. 4526, (2006)\nM.Roach 3rd and A.Izaguirre, Expert Opin. Pharmacother., 8, 257 (2007)\nR.M.Herrmann et al., Rad. Oncol., 2, 31 (2007)
Cas：65807-02-5
